About the establishment of the new organization "Integrated Research Department of Bioanalysis"

Regarding the establishment of the new organization "Integrated Research Department of Bioanalysis" - Providing comprehensive analytical support from pharmaceutical research and development to manufacturing.

Our company (hereinafter referred to as "TRC") has established the "Integrated Bioanalysis Research Department" as of April 1st, by consolidating departments responsible for structural analysis, characterization analysis, stability testing, and quality testing, in order to strengthen support for the research and development of diverse biopharmaceuticals represented by antibody drugs, nucleic acid/mRNA drugs, and cell therapies. Traditionally, TRC has provided analytical support at various stages of drug development, including structural analysis and method development to support drug discovery research, pharmacokinetic analysis under GLP conditions, and stability testing under GMP conditions. However, in response to the recent acceleration and diversification of drug development, we determined that an integrated organization of the traditional analytical departments would be effective, leading to the establishment of the new organization. The Integrated Bioanalysis Research Department brings together staff engaged in analysis at all stages of drug development to provide high-quality analytical services to our customers in a seamless manner. This will enhance the sophistication of the ever-evolving analytical technologies for biopharmaceuticals while strengthening our proposal capabilities to customers and aiming for further evolution of our services. Under the fundamental principle of "contributing to society with advanced technology," TRC will continue to grow together with our customers through the analytical expertise and quality cultivated over many years, contributing to the life sciences field, including drug development.

others